Please login to the form below

Not currently logged in

Syros Pharmaceuticals

This page shows the latest Syros Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Latest Intelligence

  • Deal Watch January 2018

    Option, collaboration. 1, 063. Syros Pharmaceuticals/ Incyte. Gene control platform to identify up to seven therapeutic targets with a focus in myeloproliferative neoplasms. ... Licence. 217. Teva Pharmaceuticals/ Alder Biopharmaceuticals. Patents

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Syros appoints Moderna CEO to board Syros appoints Moderna CEO to board

    Stéphane Bancel also has experience at bioMérieux and Lilly. The founding CEO of Moderna Therapeutics, Stéphane Bancel, has joined the board of Syros Pharmaceuticals. ... Syros, which focuses on controlling a person's genes to treat cancer and other

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company

Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....